Department of Human Structure and Repair, Faculty of Medicine, Ghent University, Ghent, Belgium.
Division of HPB, Minimally Invasive and Robotic Surgery, Department of Clinical Medicine and Surgery, Federico II University Naples, Via S. Pansini 5, 80131, Naples, Italy.
Updates Surg. 2020 Dec;72(4):925-938. doi: 10.1007/s13304-020-00859-7. Epub 2020 Aug 4.
Post hepatectomy liver failure (PHLF) could occur even though an adequate liver volume is preserved. Liver function is not strictly related to the volume and the necessity to pre-operatively predict the future liver remnant (FLR) function is emerging, together with the wide spreading of techniques, aiming to optimize the FLR. The aim of this study was to systematically review all the available tests, to pre-operatively assess the liver function and to estimate the risk of PHLF. A systematic literature research of Medline, Embase, Scopus was performed in accordance to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, to identify all the studies available for pre-operative liver function tests to assess the risk of PHLF and/or complications. From the 1122 references retrieved, 79 were included in the review. Dynamic functional tests, such as indocyanine green test (ICG), could evaluate only global liver function, with no definition of functional capacity of the remnant. Magnetic resonance imaging (MRI) with liver-specific contrast agents enables both liver function and volume evaluation; the absence of ionizing radiation showed a better patient's compliance. Nuclear imaging studies as hepatobiliary scintigraphy (HBS) present the unique ability to allow a precise evaluation of the segmental liver function of the remnant liver. Liver volume could overestimate liver function. Several liver function tests are available to evaluate the risk of PHLF in the pre-operative setting. However, no single test alone could accurately predict PHLF. Pre-operative combination between a dynamic quantitative test, such as ICG, with MRI or HBS, should enable a more complete functional evaluation. Functional tests to predict PHLF should be chosen according to patient's characteristics, disease, and center experience.
即使保留了足够的肝体积,也可能发生肝切除术后肝功能衰竭(PHLF)。肝功能与肝体积并不严格相关,因此需要术前预测剩余肝体积(FLR)的功能,同时广泛应用各种技术以优化 FLR。本研究的目的是系统地回顾所有可用的检测方法,以术前评估肝功能并估计 PHLF 的风险。按照系统评价和荟萃分析的首选报告项目(PRISMA)指南,对 Medline、Embase、Scopus 进行了系统的文献检索,以确定所有可用于术前肝功能检测以评估 PHLF 和/或并发症风险的研究。从检索到的 1122 篇参考文献中,有 79 篇被纳入综述。动态功能试验,如吲哚菁绿试验(ICG),只能评估整体肝功能,而无法定义残肝的功能容量。具有肝脏特异性对比剂的磁共振成像(MRI)可同时评估肝功能和肝体积;无电离辐射显示出更好的患者依从性。核医学成像研究如肝胆闪烁显像(HBS)具有独特的能力,可以精确评估剩余肝脏的节段性肝功能。肝体积可能会高估肝功能。有几种肝功能检测可用于评估术前发生 PHLF 的风险。然而,没有任何单一的检测方法可以准确预测 PHLF。术前将动态定量检测(如 ICG)与 MRI 或 HBS 相结合,应能进行更全面的功能评估。预测 PHLF 的功能检测应根据患者的特点、疾病和中心经验进行选择。